NCT03573557 is a NA clinical trial of Pink Pad in Vaginal Surgery, sponsored by Case Comprehensive Cancer Center.

Who is sponsoring NCT03573557?

NCT03573557 is sponsored by Case Comprehensive Cancer Center.

What drugs are being tested in NCT03573557?

Interventions in NCT03573557: Pink Pad, Bean Bag, Gel Pad.

What condition does NCT03573557 study?

NCT03573557 studies Vaginal Surgery, Laparoscopic Surgery.

Is NCT03573557 still recruiting?

NCT03573557 is currently completed. Last updated 23 March 2022.

Last reviewed 2022-03-23 · How we verify

NCT03573557

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Improved Intra-operative Safety From Optimal Selection of Anti-slip Surface

Completed NA Last updated 23 March 2022

What this trial tests

NA trial testing Pink Pad in Vaginal Surgery in 159 participants. Completed in 17 December 2019.

Timeline

5 June 2018

Primary endpoint
17 December 2019

17 December 2019

Quick facts

Lead sponsor	Case Comprehensive Cancer Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	159
Start date	5 June 2018
Primary completion	17 December 2019
Estimated completion	17 December 2019
Sites	1 location across United States

Drugs / interventions tested

Pink Pad
Bean Bag
Gel Pad

Conditions studied

Vaginal Surgery — all drugs for Vaginal Surgery →
Laparoscopic Surgery — all drugs for Laparoscopic Surgery →

Sponsor

Case Comprehensive Cancer Center — full company profile →

Who can join

18 and older, female only, with Vaginal Surgery or Laparoscopic Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To identify the best surface to minimize the risk of intra-operative slipping when placed in Trendelenburg position. The outcomes of interest are to minimize the amount of movement from predefined anatomic landmarks and maximize the ease of performing the intended surgery. The study consists of performing a randomized trial comparing 3 common anti-slip surfaces to determine which surface provides the best result in terms of safety and cost.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Case Comprehensive Cancer Center trials

Trials by the same sponsor.

NCT06811454 — Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET) · NA · not yet recruiting
NCT07167056 — Artificial Intelligence-Powered Support For Quality Of Life Improvement In Participants With Cancer · NA · recruiting
NCT07084779 — Investigation of Impact of AI on Prostate Cancer Workflow · NA · recruiting
NCT06904482 — Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood · Phase 2 · recruiting
NCT07044362 — Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03573557 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Case Comprehensive Cancer Center
Last refreshed: 23 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03573557.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing